Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype

Author(s):
Broekman, M.M.T.J.; Coenen, M.J.H.; Wanten, G.J.; Marrewijk, C.J. van; Klungel, O.H.; Verbeek, A.L.M.; Hooymans, P.M.; Guchelaar, H.J. (0000-0002-7085-1383); Scheffer, H.; Derijks, L.J.J.; Wong, D.R.; Jong, D.J. de
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-11-30
Language
English
Is part of
Alimentary Pharmacology and Therapeutics (2017), Vol. 46, no. 10, p. 953-963
hdl
1887/114943
doi
10.1111/apt.14323